Search

Displaying results 2211 - 2220 of 4646 in total
  1. Target

    Ribose-5-phosphate isomerase A

    go.drugbank.com/bio_entities/BE0001628
    TargetShigella flexneri

    Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate.

    Synonyms: PRI
  2. Target

    Ribose-5-phosphate isomerase A

    go.drugbank.com/bio_entities/BE0003268
    TargetHaemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)

    Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate.

    Synonyms: PRI
  3. Drug

    Tivozanib

    go.drugbank.com/drugs/DB11800
    ApprovedInvestigational

    The average age of diagnosis is between age 65 to 74.

  4. Target

    Cholinesterase

    go.drugbank.com/bio_entities/BE0002180
    TargetEnzymeHumans

    Esterase with broad substrate specificity. Contributes to the inactivation of the neurotransmitter acetylcholine. Can degrade neurotoxic organophosphate esters

    Synonyms: CHE1
  5. Drug

    Hexocyclium

    go.drugbank.com/drugs/DB06787
    Approved

    Hexocyclium is a muscarinic acetylcholine receptor antagonist which was presumably used in the treatment of gastric ulcer or diarrhea. It was once available under the tradename Tral marketed by Abbvie Inc. but has been discontinued. Prot...

  6. Drug

    Abaloparatide

    go.drugbank.com/drugs/DB05084
    ApprovedInvestigational

    [L740] In October 2022, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended abaloparatide be granted marketing authorization in Europe [L43552] and the drug was fully authorized

  7. Drug

    Somatrem

    go.drugbank.com/drugs/DB09098
    ApprovedWithdrawn

    ability of almost all contemporary recombinant growth hormones to cause definite and demonstrable increases in growth rate in patients who are administered the drug, the use of these agents continues to be … Such discussion revolves around whether patients' natural disposition of short stature should be considered a medical condition justifying medical treatment with such hormone therapy - especially when

    Mixtures: Protropin Pws 5mg/vial, Protropin - Kit Im Sc 5mg/vial
  8. Drug

    Calaspargase pegol

    go.drugbank.com/drugs/DB14730
    ApprovedInvestigational

    The asparagine specific enzyme is derived from Escherichia coli, as a conjugate of L-asparaginase (L-asparagine amidohydrolase) and monomethoxypolyethylene glycol (mPEG) with a succinimidyl carbonate (

    Categories: L-asparaginase containing drugs
  9. Drug

    RAF-265

    go.drugbank.com/drugs/DB05984
    Investigational

  10. Drug

    Antihemophilic factor (recombinant), PEGylated

    go.drugbank.com/drugs/DB09329
    ApprovedInvestigational

    with at least one molecule of polyethylene glycol (MW 20 kDa) [FDA label]. … Antihemophilic Factor (Recombinant), PEGylated, is a recombinant full-length human coagulation factor VIII (2,332 amino acids with a molecular weight (MW) of approximately 280 kDa) covalently conjugated